- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Formulation Development of a Nucleotide Phosphoramidate
Manoj Maniar, PhD
Pharmaceutical Technology, Pharmaceutical Technology-06-02-2003, Volume 27, Issue 6
A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.